Venus Remedies Ltd.

BSE: VENUSREM526953ISIN INE411B01019

Healthcare
Pharmaceuticals

BSE listing

Share price

₹1,590.05+40.05 (+2.58%)

as of 18 Sep 2026

52W high: ₹2,043.15
52W low: ₹423.70
Off 52W high: -22.18%
1M return: -10.32%
3M return: -9.63%
6M return: +83.39%
1Y return: +265.49%
20D avg volume: 2,365
50 DMA: ₹1,663.05
200 DMA: ₹1,171.08

Key ratios Consolidated

Market cap: ₹2,125 Cr
Current price: ₹1,590.05
52W high / low: ₹2,043.15 / ₹423.70
Face value: ₹10.00
P/E: 18.30
P/B: —
EPS (TTM): ₹86.91
Book value / share: —
ROE: —
ROCE: 19.40%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-25.12 Cr
Interest cover: 3,354.75
Dividend yield: 0.63%
Dividend / share (TTM): ₹10.00
Payout: 11.51%
Cash conversion cycle: 56.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	178.86	259.40	180.26	192.75	131.90	194.97	—
	2.62	4.95	2.52	1.71	8.69	6.76	—
	151.44	202.75	149.31	167.97	127.98	170.69	—
	83.14	116.28	93.86	106.51	71.33	104.21	—
	1.12	4.73	1.90	1.86	2.27	2.13	—
	23.37	24.56	20.83	22.97	20.30	21.16	—
	0.00	0.01	0.01	0.01	0.01	0.01	—
	6.77	6.76	6.56	6.17	6.18	4.71	—
	37.02	51.86	35.66	31.51	27.34	41.75	—
	30.04	61.60	33.47	26.49	12.61	31.04	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	30.04	61.60	33.47	26.49	12.61	31.04	—
	7.07	14.11	7.89	6.36	3.01	7.11	—
	22.97	47.49	25.58	20.13	9.60	21.00	—
	17.18	35.53	19.14	15.06	7.18	15.71	—
Key metrics
	36.81	68.37	40.04	32.67	18.80	35.76	—
	20.60%	26.40%	22.20%	16.90%	14.30%	18.30%	—
	12.80%	18.30%	14.20%	10.40%	7.30%	10.80%	—
	—	8.90%	—	4.20%	—	5.40%	—
	35.60%	33.00%	—	—	—	—	—
	139.30%	126.10%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	811.27	769.60	647.89	—
	11.80	12.58	20.96	—
	671.47	648.03	606.93	—
	399.79	387.98	348.77	—
	9.61	10.76	25.04	—
	91.73	88.68	80.49	—
	0.03	0.04	0.07	—
	26.26	25.67	22.51	—
	156.05	146.37	125.24	—
	151.60	134.15	61.92	—
	0.00	0.00	9.91	—
	151.60	134.15	71.83	—
	35.43	31.37	23.58	—
	116.17	102.78	45.32	—
	86.91	76.89	33.90	—
Key metrics
	177.89	159.86	94.41	—
	21.93%	20.80%	14.60%	—
	14.32%	13.40%	7.00%	—
	—	19.40%	12.40%	—
	—	18.80%	—	—
	—	126.80%	—	—
	—	118.11	76.82	—
	—	1.52	1.91	—
	—	0.00	0.00	—
	—	-25.12	-55.83	—
	—	56.6	68.0	—
Balance sheet
	—	853.71	715.72	—
	—	395.21	451.72	—
	—	25.12	57.52	—
	—	103.28	112.22	—
	—	129.37	100.49	—
	—	50.44	63.10	—
	—	125.43	124.70	—
	—	113.49	91.86	—
	—	161.76	136.29	—
	—	0.00	1.69	—
	—	0.00	1.69	—
	—	0.00	0.00	—
	—	663.75	560.95	—
Cash flow
	—	155.76	86.45	—
	—	-181.56	-76.25	—
	—	-3.12	-1.02	—
	—	37.65	9.63	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	178.80	259.01	179.95	192.65	131.85	194.04	—
	2.55	4.64	2.41	1.68	8.00	6.77	—
	148.75	206.07	149.55	168.73	125.15	175.98	—
	83.14	116.25	93.86	106.51	71.33	104.21	—
	1.12	4.73	1.90	1.87	2.27	2.13	—
	22.56	23.62	19.94	22.03	19.26	19.32	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	6.51	6.50	6.32	5.92	5.95	4.49	—
	35.40	56.42	37.04	33.46	25.79	49.83	—
	32.60	57.58	32.81	25.60	14.70	24.83	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	32.60	57.58	32.81	25.60	14.70	24.83	—
	7.07	14.11	7.89	6.36	3.01	7.11	—
	25.53	43.47	24.92	19.24	11.69	14.79	—
	19.10	32.51	18.64	14.40	8.75	11.07	—
Key metrics
	39.11	64.08	39.13	31.52	20.65	29.32	—
	21.90%	24.70%	21.70%	16.40%	15.70%	15.10%	—
	14.30%	16.80%	13.80%	10.00%	8.90%	7.60%	—
	—	8.00%	—	3.90%	—	4.10%	—
	35.60%	33.50%	—	—	—	—	—
	118.40%	193.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	810.41	768.73	639.46	—
	11.28	11.45	20.78	—
	673.10	649.50	591.09	—
	399.76	387.95	348.82	—
	9.62	10.76	25.04	—
	88.15	84.85	72.24	—
	0.00	0.00	0.00	—
	25.25	24.69	21.62	—
	162.32	152.72	122.44	—
	148.59	130.68	69.15	—
	0.00	0.00	9.91	—
	148.59	130.68	79.06	—
	35.43	31.37	23.58	—
	113.16	99.31	52.55	—
	84.65	74.29	39.32	—
Key metrics
	173.84	155.37	100.68	—
	21.45%	20.20%	15.70%	—
	13.96%	12.90%	8.20%	—
	—	18.20%	13.00%	—
	—	20.20%	—	—
	—	89.00%	—	—
	—	113.43	73.52	—
	—	1.52	1.58	—
	—	0.00	0.00	—
	—	-23.54	-55.41	—
	—	64.1	74.9	—
Balance sheet
	—	876.06	713.22	—
	—	405.81	435.75	—
	—	23.54	55.41	—
	—	116.39	99.26	—
	—	129.37	100.49	—
	—	49.68	62.68	—
	—	110.23	110.93	—
	—	110.77	68.61	—
	—	158.23	105.24	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	689.63	589.50	—
Cash flow
	—	151.09	83.10	—
	—	-181.57	-76.20	—
	—	-1.39	0.00	—
	—	37.66	9.58	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 41.76%

Holder	Type	Holding	Previous	Change
Sunev Pharma Solutions Pvt Ltd	Promoter Group	17.21%	—	—
PAWAN CHAUDHARY	Promoter	12.82%	—	—
MANU CHAUDHARY	Promoter	11.73%	—	—
TIKRI PARTNERS LLP	Public	1.97%	—	—
RAJNI TARUN JAIN	Public	1.42%	—	—
ACADIAN EMERGING MARKETS MICRO-CAP EQUITY MASTER FUND	Public	1.10%	—	—
NISARG AJAYKUMAR VAKHARIA	Public	1.05%	—	—
Investor Education & Protection Fund (IEPF(	Public	1.00%	—	—
Tark AI Pvt Ltd	Promoter Group	0.00%	—	—
Spine Software Systems Pvt Lt	Promoter Group	0.00%	—	—
PEEYUSH JAIN	Promoter Group	0.00%	—	—
SARANSH CHAUDHARY	Promoter Group	0.00%	—	—
Radha Luxmi Investments	Promoter Group	0.00%	—	—
ALKA JAIN	Promoter Group	0.00%	—	—
AKSHANSH CHAUDHARY	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Newspaper publication of shareholder notice on Transfer of physical shares.10 Sep 2026 · Company Update / Newspaper Publication
Newspaper publication for shareholders awareness on transfer of physical shares.9 Sep 2026 · Company Update / Newspaper Publication
As per the pdf enclosed.8 Sep 2026 · Company Update / General
As per file enclosed.21 Aug 2026 · AGM/EGM / AGM
As per the file enclosed.21 Aug 2026 · Company Update / Amendments to Memorandum & Articles of Association
As per enclosed file.21 Aug 2026 · AGM/EGM / AGM
As per the file enclosed.20 Aug 2026 · Company Update / Change in Management
As per file enclosed.20 Aug 2026 · AGM/EGM / AGM
As per enclosed file.4 Aug 2026 · Company Update / Newspaper Publication
Newspaper publication of 37th AGM Notice.27 Jul 2026 · Company Update / Newspaper Publication
Annual report for FY 2025-26.24 Jul 2026 · Others / Reg. 34 (1) Annual Report
Annual report for the FY 2025-26.24 Jul 2026 · Others / Reg. 34 (1) Annual Report
As per the pdf enclosed.24 Jul 2026 · AGM/EGM / AGM
As per the pdf enclosed.22 Jul 2026 · Company Update / Newspaper Publication
As per the pdf enclosed.20 Jul 2026 · Company Update / Amendments to Memorandum & Articles of Association
As per pdf enclosed.20 Jul 2026 · Result / Financial Results
As per the pdf enclosed.20 Jul 2026 · Board Meeting / Outcome of Board Meeting
As per pdf enclosed.18 Jul 2026 · Company Update / General
As per the file enclosed.10 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2026 ,inter alia, to consider and approve This is to inform you that the ....9 Jul 2026 · Board Meeting / Board Meeting
As per the pdf enclosed.7 Jul 2026 · Company Update / General
Copy of newspaper publication for AGM prior Notice.3 Jul 2026 · Company Update / Newspaper Publication
Closure of Trading window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
As per file enclosed.16 Jun 2026 · Company Update / General
As per the PDF enclosed.4 Jun 2026 · Company Update / General
As per enclosed file.28 May 2026 · Company Update / Newspaper Publication
As per the file enclosed26 May 2026 · Corp. Action / Dividend
AS per file enclosed.26 May 2026 · Company Update / General
Appointments & reappointments of directors.26 May 2026 · Company Update / Change in Management
As per file attached.26 May 2026 · Corp Action / Dividend Updates
As per file enclosed26 May 2026 · Result / Financial Results
As the file enclosed.26 May 2026 · Board Meeting / Outcome of Board Meeting
As per the pdf enclosed22 May 2026 · Company Update / General
Social media Post on KYC updation.21 May 2026 · Company Update / General
Board meeting is scheduled for 26th May 2026.15 May 2026 · Corp. Action / Dividend
Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Board meeting scheduled for ....15 May 2026 · Board Meeting / Board Meeting
Annual Secretarial Compliance report for the Year ended on 31st March as per Reg 24(A) of SEBI LODR.6 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Newspaper publication of Notice to shareholders about transfer of physical shares as per SEBI circular.5 May 2026 · Company Update / Newspaper Publication
Disclosure of social media post on details about Transfer of physical shares.4 May 2026 · Company Update / General
Social Media post informing shareholder about limited period window for physical transfer of shares.8 Apr 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 10.0000	7 Aug 2026	7 Aug 2026	—

Board meetings

20 Jul 2026 Board Meeting - Financial Results